Clinical Trial: ARTIDIS Nanomechanical Generated Measurements for Early Breast Lesions
Study Status: Completed
Recruit Status: RECRUITING
Condition: Breast Cancer
Study Type: INTERVENTIONAL
Official Title: ARTIDIS Nanomechanical Generated Measurements for Early Breast Lesions (ANGEL)
Brief Summary:
This prospective, blinded, single-arm study aims to test the performance of nanomechanical phenotype in predicting tumor type, tumor aggressiveness, and neoadjuvant treatment response compared to the gold standard of histopathological assessment.The study involves patients with suspicious breast lesions who will undergo a breast biopsy procedure indicated by standard of care.The nanomechanical phenotype will be measured on the freshly obtained breast biopsies or tissue from breast surgeries.
Read more